Menu
Log in
Forgot password



Your Resource for Neurotherapeutics Discovery and Development


Log in
  • Home
  • Annual Meeting

Annual Meeting Overview

BECOME A SUPPORTER  FINAL PROGRAM  

REGISTER TO ATTENDBOOK YOUR HOTEL ROOM

Join us as the American Society for Experimental Neurotherapeutics Annual Meeting (ASENT 2025) will be held at Hyatt Regency Bethesda, in Bethesda, MD from March 12-14, 2025. 

ASENT's 2025 Annual Meeting is the premier neuroscience and neurotherapeutics conference where senior leaders from healthcare payers, providers and prescribers, employers, investors, fast-growing startups, big pharma, policymakers, funders and innovation centers gather to improve the process of bringing neurotherapeutics to market.

The Meeting features 12 symposia, which address therapeutic advances in a broad range neurologic disease states, processes and delivery methods; as well as interactive poster presentations, ASENT's celebrated pipeline presentations, and live discussion with speakers at the end of each day. 

2025 Meeting Highlights 

    • 12 - 16 Scientific Symposia featuring Neuroscience leaders from Industry, Academia, FDA, NIH, and Advocacy
    • DEBATE: Featuring a hot topic and current data
    • CNS PIPELINE Presentations
    • CAREER DINNER Featuring Guest Speakers
    • Interactive Poster Discussions
    • Sponsored Symposia from Innovation Leaders
    • Live Discussions in Breakout Rooms with Speakers
    • 2nd Annual Neurotherapeutics Clinical Trial Course - LIVE  (application only)


    This year our program will include symposia on:

    • Gene targeted therapy for Epilepsy
    • Universal Framework for Staging of Neurodegenerative Diseases
    • A Broader Look at Patient Focused Drug Development
    • Immunotherapy of Neurodegenerative Disorders
    • An Update on Pediatric Neurotherapeutics
    • Novel Therapies in Duchenne and Becker’s Muscular Dystrophy
    • Global Neuroinfectious Disease
    • Autoimmune Therapeutics presented inconjunction with the Japanese Society of Neurological Therapeutics
    • Diversity and Equity in Clinical Trials
    • ”Tell me about it” speech analysis in Neurodegenerative Diseases
    • Update on Pain Therapeutic Opportunities
    • Updates in Neurovascular and Stroke Therapeutics
    • Interactive Poster Discussions
    • Dynamic Pipeline Presentations
    • Live Discussions in Breakout Rooms with Speakers
    • And much, much more!


    Meeting Location

    Hyatt Regency Bethesda, Bethesda MD

    BOOK YOUR ROOM


    Who Attends

    50% of attendees are practicing physicians| Physician-Scientists | Neurologists | Neuroscientists | Drug and Device Companies | Fellows | Post-docs | Founders | Funders | Industry Leaders | Nonprofit Organizations and Advocacy Groups | Journal Editors | Representatives from NIH, NIA, NIDA, NINDS and FDA

    The 2025 meeting will feature a high number of junior faculty and trainees as attendees at our clinical trials course and neurotherapeutic drug discovery course are welcome to attend the annual meeting at a discounted cost. 

    Neurology students and residents interested in neurotherapeutic development will benefit from the insight of senior investigators and leaders in industry, while private practice neurologists considering entering the clinical trial space will benefit from lessons learned by ASENT leadership. The Annual Meeting features career development sessions that offer strategies for achieving professional success in the field of neurotherapeutics. 

    Cancellation Policy

    You may cancel your registration for a refund through February 28, 2025. Cancellations will be refunded less a $50 cancellation fee. No refunds will be granted for cancellations on March 1, 2025, and after.


    Upcoming events

    • ASENT Neurotherapeutics Innovation Networking Reception

      • May 27, 2025
      • 6:00 PM - 8:00 PM
      • Catalyst Restaurant, 300 Technology Square, Cambridge, MA 02139
      Register

      Neurotherapeutics Networking Reception

      ASENT invites you to join us at Catalyst Restaurant in Cambridge, MA, to connect with peers focused on drug and device development in the area of Neurotherapeutics.

      You will hear from our new president Ludy Shih, MD, MMSc, and from our guest speaker Kiran Reddy, MD, MBA, Senior Managing Director in the Blackstone Life Sciences group. Kiran will share a little on his experience as a presenter at the recent ASENT Annual Meeting. 

      This event will take place at:

      Catalyst Restaurant
      300 Technology Square
      Cambridge, MA 02139

      6:00 - 8:00 pm

      Complimentary validated parking is available in the Technology Square garage.

      Drinks and Light Appetizers will be served

      Join in a short moderated discussion with our guest speakers (see bios below) followed by Q&A and networking.

      GUEST SPEAKERS
      Kiran Reddy, MD, MBA
      Kiran Reddy is a Senior Managing Director in the Blackstone Life Sciences group having joined in May 2020. Dr. Reddy was previously the President & CEO of Praxis Precision Medicines, which he co-founded in November 2016.

      Previously, Dr. Reddy was at Biogen where he was part of the corporate develop and strategy leadership team. Dr. Reddy was also an Associate Partner at Third Rock Ventures. He supported and managed various portfolio companies in addition to focusing on new company formation and new investments. He was part of the founding team and interim Chief Business Officer for SAGE Therapeutics through its IPO. Dr. Reddy was part of the team that launched Foundation Medicine, and he has served as a Board Observer for Alnara pharmaceuticals, Rhythm pharmaceuticals and PanOptica pharmaceuticals.

      Dr. Reddy holds MD and MBA degrees from Georgetown University. He completed his internship in medicine and his neurology residency at Harvard/Massachusetts General Hospital. Dr. Reddy was previously a Howard Hughes science fellow and has authored several peer-reviewed scientific papers in the field of epilepsy, neuroimmunology and neurodegenerative diseases.

      Ludy Shih, M.D., M.M.Sc.
      Dr. Ludy Shih received her MD from the University of California School of Medicine, Los Angeles and completed her internship, neurology residency, and movement disorders fellowship at Harvard Medical School/Beth Israel Deaconess Medical Center (BIDMC) and completed a master’s in clinical investigation through the Harvard-MIT Health Sciences and Technology Clinical Investigator Training Program. She has been an active clinical investigator in Parkinson's disease and essential tremor throughout her career. In addition, she worked at Biogen and Vertex Pharmaceuticals in early stage clinical development, designing studies for Parkinson's disease and genetic movement disorders. She is a Fellow of the American Academy of Neurology, and the American Neurological Association, and serves as Associate Editor at Annals of Clinical and Translational Neurology. She has been as a member of ASENT since 2017 and has served as a member as well as co-chair of the Scientific Program Committee and currently serves as ASENT’s President.

      Jessica K. Smith
      Jessica Keenan Smith is Executive Director of the American Society for Experimental Neurotherapeutics (ASENT), an organization that brings together leaders from industry, academia, government and advocacy who are engaged in bringing drugs and devices to market across all neurologic disease states. Ms. Smith is also Founder and CEO of Living Well With Epilepsy, an online platform that provides in-depth information on epilepsy to those living with the disease and their loved ones. By holding both these roles simultaneously, she bridges the gap between the scientific and patient communities. As an award-winning professional with more than two decades of experience in healthcare, higher education and nonprofit sectors, Ms. Smith has led organizations to achieve outstanding results.


      Show details
    Powered by Wild Apricot Membership Software